Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$277.49
5.051.85%
At close: -
$277.01
-0.48-0.17%
After Hours: 6:26 PM EDT
Comments
Loading...
Amgen Analyst Ratings and Price Targets | NASDAQ:AMGN | Benzinga
Amgen Inc has a consensus price target of $314.97 based on the ratings of 34 analysts. The high is $405 issued by Cantor Fitzgerald on October 22, 2024. The low is $200 issued by Credit Suisse on July 12, 2023. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Guggenheim, and Piper Sandler on June 24, 2025, May 20, 2025, and May 16, 2025, respectively. With an average price target of $307 between Cantor Fitzgerald, Guggenheim, and Piper Sandler, there's an implied 10.83% upside for Amgen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Guggenheim
Piper Sandler
Mizuho
UBS
1calculated from analyst ratings
Analyst Ratings for Amgen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2025 | Buy Now | 10.11% | Cantor Fitzgerald | Carter Gould56% | $305 → $305 | Reiterates | Neutral → Neutral | Get Alert |
| 05/20/2025 | Buy Now | 3.97% | Guggenheim | Vamil Divan74% | → $288 | Assumes | → Neutral | Get Alert |
| 05/16/2025 | Buy Now | 18.41% | Piper Sandler | David Amsellem73% | $329 → $328 | Maintains | Overweight | Get Alert |
| 05/07/2025 | Buy Now | 1.08% | Mizuho | Salim Syed43% | $235 → $280 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | 13.72% | UBS | Trung Huynh71% | $319 → $315 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | 15.52% | RBC Capital | Gregory Renza49% | $324 → $320 | Maintains | Outperform | Get Alert |
| 04/14/2025 | Buy Now | 15.16% | UBS | Colin Bristow38% | $315 → $319 | Maintains | Neutral | Get Alert |
| 04/09/2025 | Buy Now | 19.13% | Morgan Stanley | Terence Flynn64% | $328 → $330 | Maintains | Equal-Weight | Get Alert |
| 03/05/2025 | Buy Now | 6.13% | B of A Securities | Tim Anderson65% | $275 → $294 | Maintains | Underperform | Get Alert |
| 02/10/2025 | Buy Now | 18.77% | Piper Sandler | David Amsellem73% | $310 → $329 | Maintains | Overweight | Get Alert |
| 02/06/2025 | Buy Now | -0.72% | B of A Securities | Tim Anderson65% | $256 → $275 | Maintains | Underperform | Get Alert |
| 02/05/2025 | Buy Now | 18.41% | Morgan Stanley | Terence Flynn64% | $322 → $328 | Maintains | Equal-Weight | Get Alert |
| 01/29/2025 | Buy Now | 24.91% | BMO Capital | Evan David Seigerman48% | $362 → $346 | Maintains | Outperform | Get Alert |
| 01/28/2025 | Buy Now | 6.5% | Citigroup | Geoff Meacham61% | $310 → $295 | Maintains | Neutral | Get Alert |
| 01/24/2025 | Buy Now | 16.96% | RBC Capital | Gregory Renza49% | $324 → $324 | Reiterates | Outperform → Outperform | Get Alert |
| 01/10/2025 | Buy Now | 1.08% | Wells Fargo | Mohit Bansal67% | $335 → $280 | Maintains | Equal-Weight | Get Alert |
| 01/08/2025 | Buy Now | 7.58% | Truist Securities | Robyn Karnauskas54% | $333 → $298 | Maintains | Hold | Get Alert |
| 01/02/2025 | Buy Now | 11.91% | Piper Sandler | David Amsellem73% | $344 → $310 | Maintains | Overweight | Get Alert |
| 12/10/2024 | Buy Now | -7.58% | B of A Securities | Tim Anderson65% | → $256 | Reinstates | → Underperform | Get Alert |
| 11/27/2024 | Buy Now | 19.13% | RBC Capital | Gregory Renza49% | $360 → $330 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | — | Wolfe Research | Tim Anderson65% | — | Initiates | → Peer Perform | Get Alert |
| 11/14/2024 | Buy Now | 20.94% | Citigroup | Geoff Meacham61% | → $335 | Initiates | → Neutral | Get Alert |
| 11/12/2024 | Buy Now | 37.18% | Jefferies | Michael Yee56% | $380 → $380 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 17.69% | UBS | Colin Bristow38% | $335 → $326 | Maintains | Neutral | Get Alert |
| 10/22/2024 | Buy Now | 46.21% | Cantor Fitzgerald | Olivia Brayer53% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 10/21/2024 | Buy Now | 38.26% | TD Cowen | Yaron Weber41% | $381 → $383 | Maintains | Buy | Get Alert |
| 10/17/2024 | Buy Now | 37.18% | Bernstein | Aaron Gal54% | → $380 | Initiates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | 20.21% | Truist Securities | Robyn Karnauskas54% | $320 → $333 | Downgrade | Buy → Hold | Get Alert |
| 10/07/2024 | Buy Now | 13.72% | Barclays | Carter Gould56% | $300 → $315 | Maintains | Equal-Weight | Get Alert |
| 09/27/2024 | Buy Now | 46.21% | Cantor Fitzgerald | Olivia Brayer53% | → $405 | Initiates | → Overweight | Get Alert |
| 09/26/2024 | Buy Now | 30.68% | RBC Capital | Gregory Renza49% | $362 → $362 | Reiterates | Outperform → Outperform | Get Alert |
| 09/25/2024 | Buy Now | -22.38% | Baird | Brian Skorney58% | $215 → $215 | Reiterates | Underperform → Underperform | Get Alert |
| 08/07/2024 | Buy Now | 37.54% | TD Cowen | Yaron Weber41% | $360 → $381 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 37.18% | Oppenheimer | Jay Olson60% | $380 → $380 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 10.11% | Deutsche Bank | James Shin46% | $310 → $305 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2024 | Buy Now | 19.13% | B of A Securities | Geoff Meacham61% | $325 → $330 | Maintains | Neutral | Get Alert |
| 08/07/2024 | Buy Now | 30.68% | RBC Capital | Gregory Renza49% | $332 → $362 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 20.94% | Wells Fargo | Mohit Bansal67% | $320 → $335 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 21.66% | UBS | Colin Bristow38% | $307 → $337 | Maintains | Neutral | Get Alert |
| 07/11/2024 | Buy Now | 9.38% | Morgan Stanley | Terence Flynn64% | $310 → $303 | Maintains | Equal-Weight | Get Alert |
| 06/27/2024 | Buy Now | 22.74% | Argus Research | David Toung68% | $300 → $340 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | 19.85% | RBC Capital | Gregory Renza49% | $328 → $332 | Maintains | Outperform | Get Alert |
| 05/09/2024 | Buy Now | -15.16% | Mizuho | Salim Syed43% | $223 → $235 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 18.41% | RBC Capital | Gregory Renza49% | $332 → $328 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 11.91% | Morgan Stanley | Terence Flynn64% | $271 → $310 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 10.83% | UBS | Colin Bristow38% | $284 → $307 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | William Blair | Matthew Phipps10% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/03/2024 | Buy Now | 28.16% | BMO Capital | Evan David Seigerman48% | $336 → $355 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 8.3% | Barclays | Carter Gould56% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/17/2024 | Buy Now | 2.52% | UBS | Colin Bristow38% | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | Buy Now | 29.96% | TD Cowen | Yaron Weber41% | $370 → $360 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | 15.52% | Truist Securities | Robyn Karnauskas54% | $320 → $320 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | -2.17% | Morgan Stanley | Terence Flynn64% | $278 → $271 | Maintains | Equal-Weight | Get Alert |
| 04/03/2024 | Buy Now | 18.77% | RBC Capital | Gregory Renza49% | $329 → $329 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | Buy Now | — | Raymond James | Gary Nachman59% | — | Reinstates | → Market Perform | Get Alert |
| 02/08/2024 | Buy Now | 26.35% | Goldman Sachs | Salveen Richter51% | $313 → $350 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 0.36% | Morgan Stanley | Terence Flynn64% | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | Buy Now | 18.77% | RBC Capital | Gregory Renza49% | $303 → $329 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 26.35% | Goldman Sachs | Salveen Richter51% | $313 → $350 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | 26.35% | Oppenheimer | Jay Olson60% | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/29/2024 | Buy Now | 13.35% | UBS | Colin Bristow38% | $315 → $314 | Maintains | Neutral | Get Alert |
| 12/21/2023 | Buy Now | 15.52% | Daiwa Capital | Narumi Nakagiri23% | → $320 | Upgrade | Neutral → Buy | Get Alert |
| 12/19/2023 | Buy Now | 17.69% | BMO Capital | Evan David Seigerman48% | $286 → $326 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | 8.3% | RBC Capital | Gregory Renza49% | $256 → $300 | Upgrade | Sector Perform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | 15.52% | Truist Securities | Robyn Karnauskas54% | → $320 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | -13.36% | Deutsche Bank | James Shin46% | → $240 | Initiates | → Hold | Get Alert |
| 11/02/2023 | Buy Now | -7.58% | RBC Capital | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/02/2023 | Buy Now | 15.52% | Truist Securities | Robyn Karnauskas54% | → $320 | Upgrade | Hold → Buy | Get Alert |
| 11/02/2023 | Buy Now | -3.25% | UBS | Colin Bristow38% | $272 → $268 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | -7.58% | RBC Capital | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | 5.05% | Morgan Stanley | Terence Flynn64% | $300 → $291 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | 11.91% | Oppenheimer | Jay Olson60% | $300 → $310 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | 8.3% | Oppenheimer | Jay Olson60% | $290 → $300 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -2.53% | JP Morgan | Chris Schott59% | → $270 | Reinstates | Neutral → Neutral | Get Alert |
| 10/17/2023 | Buy Now | 11.91% | Argus Research | David Toung68% | $280 → $310 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | 8.3% | Morgan Stanley | Terence Flynn64% | → $300 | Reinstates | → Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | 11.91% | Jefferies | Michael Yee56% | $310 → $310 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | 14.8% | Leerink Partners | David Risinger71% | $267 → $318 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/11/2023 | Buy Now | 4.69% | B of A Securities | Geoff Meacham61% | → $290 | Reinstates | → Neutral | Get Alert |
| 10/09/2023 | Buy Now | 4.69% | Oppenheimer | Jay Olson60% | $280 → $290 | Maintains | Outperform | Get Alert |
| 09/18/2023 | Buy Now | 1.08% | Argus Research | David Toung68% | $260 → $280 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | 15.52% | HSBC | Morten Herholdt36% | → $320 | Initiates | → Buy | Get Alert |
| 09/05/2023 | Buy Now | -6.14% | Truist Securities | Robyn Karnauskas54% | → $260 | Reiterates | Hold → Hold | Get Alert |
| 08/14/2023 | Buy Now | 11.91% | Jefferies | Michael Yee56% | $275 → $310 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | -19.5% | Mizuho | Salim Syed43% | $214 → $223 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | -8.67% | RBC Capital | Gregory Renza49% | $250 → $253 | Maintains | Sector Perform | Get Alert |
| 07/25/2023 | Buy Now | 1.08% | Oppenheimer | Jay Olson60% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 07/12/2023 | Buy Now | -27.8% | Credit Suisse | Trung Huynh71% | $220 → $200 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -24.19% | Barclays | Carter Gould56% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/26/2023 | Buy Now | -6.14% | Argus Research | David Toung68% | $270 → $260 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | 1.08% | Oppenheimer | Jay Olson60% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | Buy Now | -8.31% | RBC Capital | Gregory Renza49% | → $254 | Reiterates | → Sector Perform | Get Alert |
| 05/01/2023 | Buy Now | -18.77% | Barclays | Carter Gould56% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/28/2023 | Buy Now | 3.97% | Piper Sandler | Christopher Raymond55% | $293 → $288 | Maintains | Overweight | Get Alert |
| 04/24/2023 | Buy Now | 4.69% | Oppenheimer | Jay Olson60% | $292 → $290 | Maintains | Outperform | Get Alert |
| 04/14/2023 | Buy Now | -18.05% | Barclays | Carter Gould56% | $230 → $227 | Maintains | Underweight | Get Alert |
| 03/13/2023 | Buy Now | -4.33% | Wells Fargo | Mohit Bansal67% | $275 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/13/2023 | Buy Now | -6.14% | Truist Securities | Robyn Karnauskas54% | $280 → $260 | Maintains | Hold | Get Alert |
| 02/02/2023 | Buy Now | -3.61% | SVB Leerink | David Risinger71% | $282 → $267 | Maintains | Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -0.72% | Wells Fargo | Mohit Bansal67% | $285 → $275 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Amgen (AMGN) stock?
The latest price target for Amgen (NASDAQ:AMGN) was reported by Cantor Fitzgerald on June 24, 2025. The analyst firm set a price target for $305.00 expecting AMGN to rise to within 12 months (a possible 10.11% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amgen (AMGN)?
The latest analyst rating for Amgen (NASDAQ:AMGN) was provided by Cantor Fitzgerald, and Amgen reiterated their neutral rating.
When was the last upgrade for Amgen (AMGN)?
The last upgrade for Amgen Inc happened on May 3, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Amgen Inc.
When was the last downgrade for Amgen (AMGN)?
The last downgrade for Amgen Inc happened on October 14, 2024 when Truist Securities changed their price target from $320 to $333 for Amgen Inc.
When is the next analyst rating going to be posted or updated for Amgen (AMGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.
Is the Analyst Rating Amgen (AMGN) correct?
While ratings are subjective and will change, the latest Amgen (AMGN) rating was a reiterated with a price target of $305.00 to $305.00. The current price Amgen (AMGN) is trading at is $277.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
